-+ 0.00%
-+ 0.00%
-+ 0.00%

Genome&Company cuts convertible bond conversion price to KRW 5,240 from KRW 6,420

PUBT·10/13/2026 07:53:05
Genome&Company cuts convertible bond conversion price to KRW 5,240 from KRW 6,420
  • Genome&Company reset the conversion price on its unlisted 4th convertible bond to KRW 5,240 from KRW 6,420.
  • Move increases shares issuable on conversion to 5,152,671 from 4,205,607 against KRW 27 billion outstanding principal.
  • Reset takes effect Oct. 13, 2026, reflecting a market-price adjustment mechanism.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genome&Company published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261013900486), on October 13, 2026, and is solely responsible for the information contained therein.